Article Watch: April 2018

Antibodies to watch in 2018

The pace of antibody therapeutics development accelerated in 2017, and this faster pace is projected to continue through 2018. Notably, the annual number of antibody therapeutics granted a first approval in either the European Union (EU) or United States (US) reached double-digits (total of 10) for the first time in 2017. The 10 antibodies granted approvals are: brodalumab, dupilumab, sarilumab...

Cover vol. 15, no. 2, April 2018

Current Resources for Evidence-Based Practice, March/April 2018.

In November, 2009, the U.S. Preventive Services Task Force (USPSTF) updated recommendations for breast cancer screening. The new guidelines, based on updated review of the evidence, recommend against routine screening mammography for women aged 40-49 in the general population, call for biennial screening mammography in women aged 50-74, and state that the evidence is insufficient to recommend c...

NSIDRC Journal Article Alert – April 2007

• Work schedule during pregnancy and spontaneous abortion. • Genetic evaluation of stillbirth in United States holsteins using a sirematernal grandsire threshold model. • Combining internal and external validation data to correct for exposure misclassification: A case study. • Activation of 5-HT1A receptors in the paragigantocellularis lateralis decreases shivering during cooling in the conscio...

Persian-translation Vol.15, No.2 April 2018